Related Experiment Video
Updated: May 6, 2026
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
8.1K
Fatal hypersensitivity pneumonitis associated with docetaxel
Tumori
|October 26, 2013
Summary
Docetaxel can cause fatal hypersensitivity pneumonitis in advanced breast cancer patients. Early recognition and aggressive steroid treatment are crucial for managing this severe lung complication.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Background:
- Docetaxel is a common chemotherapy agent for advanced breast cancer.
- Hypersensitivity pneumonitis is a rare but serious potential adverse effect of chemotherapy.
- Interstitial lung diseases can present with varied etiologies.
Observation:
- A patient with advanced breast cancer developed recurrent hypersensitivity pneumonitis after docetaxel treatment.
- The condition progressed to respiratory failure despite corticosteroids and supportive care.
- Bronchoalveolar lavage and lung biopsy confirmed docetaxel-induced hypersensitivity pneumonitis, ruling out infection and tumor spread.
Findings:
- Docetaxel administration led to severe, life-threatening hypersensitivity pneumonitis.
- The patient ultimately succumbed to the respiratory failure.
- Diagnostic procedures were essential to differentiate drug-induced pneumonitis from other causes.
Implications:
- Clinicians must consider docetaxel-induced hypersensitivity pneumonitis in patients receiving this chemotherapy who present with interstitial pneumonitis.
- Prompt and aggressive treatment with corticosteroids and supportive care is vital.
- This condition can be fatal, highlighting the importance of vigilant monitoring and early intervention.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
14.0K
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
01:26Pneumothorax-I
2.2K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.2K
01:27Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
386
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
386
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
205
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
205
01:08Pneumothorax II: Pathophysiology
108
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance...
108